In Vitro Drug Resistance Versus Chemosensitivity: Two Sides of Different Coins
- 20 May 2005
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (15), 3641-3643
- https://doi.org/10.1200/jco.2005.05.281
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay–guided chemotherapyAmerican Journal of Obstetrics and Gynecology, 2003
- Association between in Vitro Platinum Resistance in the EDR Assay and Clinical Outcomes for Ovarian Cancer PatientsGynecologic Oncology, 2002
- In vitro assay-assisted treatment selection for women with breast or ovarian cancer.Endocrine-Related Cancer, 2002
- Breast Cancer Survival and in Vitro Tumor Response in the Extreme Drug Resistance AssayBreast Cancer Research and Treatment, 2001
- Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assayBritish Journal of Haematology, 1999
- Review of the Efficacy of Individualized Chemotherapy Selected by In Vitro Drug Sensitivity Testing for Patients With CancerJournal of Clinical Oncology, 1999
- Tumor chemosensitivity and chemoresistance assaysCancer, 1996
- He's Not Going to Talk About In Vitro Predictive Assays Again, Is He?JNCI Journal of the National Cancer Institute, 1990
- IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPYThe Lancet, 1980
- Renal-Vein Thrombosis and Nephrotic Syndrome: Cause or Effect?New England Journal of Medicine, 1978